These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 19481235)

  • 1. Synthesis of novel phosphorothioates and phosphorodithioates and their differential inhibition of cholinesterases.
    Kaboudin B; Emadi S; Hadizadeh A
    Bioorg Chem; 2009 Aug; 37(4):101-5. PubMed ID: 19481235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
    Zhan ZJ; Bian HL; Wang JW; Shan WG
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
    Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
    Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of two different cholinesterases by tacrine.
    Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
    Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.
    Huang L; Luo Z; He F; Lu J; Li X
    Bioorg Med Chem; 2010 Jun; 18(12):4475-84. PubMed ID: 20471843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Pan L; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3790-3. PubMed ID: 18524585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
    Musilek K; Komloova M; Zavadova V; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K; Jung YS
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1763-6. PubMed ID: 20138518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.
    Vitorović-Todorović MD; Juranić IO; Mandić LM; Drakulić BJ
    Bioorg Med Chem; 2010 Feb; 18(3):1181-93. PubMed ID: 20061157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical synthesis of two series of nerve agent model compounds and their stereoselective interaction with human acetylcholinesterase and human butyrylcholinesterase.
    Barakat NH; Zheng X; Gilley CB; MacDonald M; Okolotowicz K; Cashman JR; Vyas S; Beck JM; Hadad CM; Zhang J
    Chem Res Toxicol; 2009 Oct; 22(10):1669-79. PubMed ID: 19715346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
    J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docking and quantum mechanic studies on cholinesterases and their inhibitors.
    Correa-Basurto J; Flores-Sandoval C; Marín-Cruz J; Rojo-Domínguez A; Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Eur J Med Chem; 2007 Jan; 42(1):10-9. PubMed ID: 17055616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
    Bosak A; Gazić I; Vinković V; Kovarik Z
    Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
    Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
    Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.
    Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Tsumura Y; Akaike A; Niidome T; Takahashi T; Sugimoto H
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1721-3. PubMed ID: 20137941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Mughal EU; Sadiq A; Murtaza S; Rafique H; Zafar MN; Riaz T; Khan BA; Hameed A; Khan KM
    Bioorg Med Chem; 2017 Jan; 25(1):100-106. PubMed ID: 27780618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
    Utku S; Gökçe M; Orhan I; Sahin MF
    Arzneimittelforschung; 2011; 61(1):1-7. PubMed ID: 21355440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.
    Takahashi J; Hijikuro I; Kihara T; Murugesh MG; Fuse S; Kunimoto R; Tsumura Y; Akaike A; Niidome T; Okuno Y; Takahashi T; Sugimoto H
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1718-20. PubMed ID: 20137934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselective acetylcholinesterase inhibition of the organophosphorous insecticides profenofos, fonofos, and crotoxyphos.
    Nillos MG; Rodriguez-Fuentes G; Gan J; Schlenk D
    Environ Toxicol Chem; 2007 Sep; 26(9):1949-54. PubMed ID: 17705656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of organophosphates with fluorine-containing leaving groups as serine esterase inhibitors with potential for Alzheimer disease therapeutics.
    Makhaeva GF; Aksinenko AY; Sokolov VB; Serebryakova OG; Richardson RJ
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5528-30. PubMed ID: 19717305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatment.
    Musilek K; Komloova M; Holas O; Hrabinova M; Pohanka M; Dohnal V; Nachon F; Dolezal M; Kuca K
    Eur J Med Chem; 2011 Feb; 46(2):811-8. PubMed ID: 21236521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.